A01=Peter Gotzsche
ADHD
ADHD Drug
Age Group_Uncategorized
Age Group_Uncategorized
ALLHAT
American Psychiatric Association
Attention Deficit Hyperactivity Disorder
Author_Peter Gotzsche
automatic-update
Big Pharma
Cardiovascular Harms
Category1=Non-Fiction
Category=JKVM
Category=MB
Category=MR
Category=PS
Category=TDCW
Class Study
clinical trial bias
CME
Colorectal Adenomas
COP=United Kingdom
Corporate Integrity Agreement
COX-2 Inhibitor
Deadly Medicines
Delivery_Delivery within 10-20 working days
Drug Agencies
eq_bestseller
eq_isMigrated=0
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
evidence-based medicine
FDA Scientist
FDA Warning
fraudulent behaviour
healthcare policy reform
Industry Trials
Interim Analyses
Language_English
medical ethics
organised crime
PA=Available
pharmaceutical industries
pharmaceutical industry malpractice
pharmaceutical regulation
political corruption
Price_€20 to €50
PS=Active
psychiatric drug safety
Randomised Trials
Seeding Trials
softlaunch
Specialty Journals
Tap Pharmaceutical
Unrestricted Educational Grants
Vigor Trial
World's Biggest Drug Company
Product details
- ISBN 9781846198847
- Weight: 508g
- Dimensions: 156 x 234mm
- Publication Date: 28 Aug 2013
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Paperback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. He convincingly draws close comparisons with the tobacco conglomerates, revealing the extraordinary truth behind efforts to confuse and distract the public and their politicians. The book addresses, in evidence-based detail, an extraordinary system failure caused by widespread crime, corruption, bribery and impotent drug regulation in need of radical reforms. "The main reason we take so many drugs is that drug companies don't sell drugs, they sell lies about drugs. This is what makes drugs so different from anything else in life...Virtually everything we know about drugs is what the companies have chosen to tell us and our doctors...the reason patients trust their medicine is that they extrapolate the trust they have in their doctors into the medicines they prescribe. The patients don't realise that, although their doctors may know a lot about diseases and human physiology and psychology, they know very, very little about drugs that hasn't been carefully concocted and dressed up by the drug industry...If you don't think the system is out of control, please email me and explain why drugs are the third leading cause of death...If such a hugely lethal epidemic had been caused by a new bacterium or a virus, or even one-hundredth of it, we would have done everything we could to get it under control." FROM THE INTRODUCTION
Professor Peter C Gøtzsche graduated as a Master of Science in biology and chemistry in 1974 and as a physician in 1984. He is a specialist in internal medicine; he worked with clinical trials and regulatory affairs in the drug industry 1975–83, and at hospitals in Copenhagen 1984–95. He co-founded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre the same year. He became professor of Clinical Research Design and Analysis in 2010 at the University of Copenhagen., Peter Gøtzsche has published more than 50 papers in ‘the big five’ (BMJ, Lancet, JAMA, Annals of Internal Medicine and New England Journal of Medicine) and his scientific works have been cited over 10000 times., Peter Gøtzsche has an interest in statistics and research methodology. He is a member of several groups publishing guidelines for good reporting of research and has co-authored CONSORT for randomised trials (www.consort-statement.org), STROBE for observational studies (www.strobe-statement.org), PRISMA for systematic reviews and meta-analyses (www.prisma-statement.org), and SPIRIT for trial protocols (www.spirit-statement.org). Peter Gøtzsche is an editor in the Cochrane Methodology Review Group.
